Immunohistochemical expression of folate receptor α in colorectal carcinoma: patterns and biological significance

• Published in: Human pathology 2008-04, Vol.39 (4), p.498-505
• Main Authors: Shia, Jinru, MD, Klimstra, David S, Nitzkorski, James R, Low, Philip S., PhD, Gonen, Mithat, Landmann, Ron, Weiser, Martin R, Franklin, Wilbur A., MD, Prendergast, Franklyn G., MD, PhD, Murphy, Linda, HT (ASCP), Tang, Laura H, Temple, Larissa, Guillem, Jose G, Wong, W. Douglas, Paty, Philip B
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Carcinoma - diagnosis; Carcinoma - pathology; Carrier Proteins - analysis; Carrier Proteins - metabolism; Colorectal carcinoma; Colorectal Neoplasms - diagnosis; Colorectal Neoplasms - pathology; Female; Folate receptor α; Folate Receptors, GPI-Anchored; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Immunohistochemical expression; Immunohistochemistry; Investigative techniques, diagnostic techniques (general aspects); Male; Medical sciences; Microsatellite Instability; Middle Aged; Pathology; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Polymerase Chain Reaction; Prognosis; Receptors, Cell Surface - analysis; Receptors, Cell Surface - metabolism; Staining and Labeling; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tissue Array Analysis; Tumors
• ISSN: 0046-8177; 1532-8392
• DOI: 10.1016/j.humpath.2007.09.013

Summary Folate receptor α (FR α ) has emerged as a potential cancer therapy target with several folate-linked therapeutic agents currently undergoing clinical trials. In addition, FR α expression in tumors may offer prognostic significance. Most studies on FR α expression used reverse transcriptase polymerase chain reaction or cytofluorimetric assays. The applicability of such methods to paraffin-embedded tissues is limited. The aims of this study were to assess the feasibility of immunohistochemistry in detecting FR α expression and to assess the patterns and clinical significance of FR α expression in colorectal tissues. We used tissue microarrays containing 152 normal colorectal mucosa samples, 42 adenomas, 177 primary, and 52 metastatic colorectal carcinomas. Our results showed that staining for FR α on colorectal tissues was simple and easy to read. FR α positivity was more frequent in carcinomas (33% in primaries and 44% in metastases) than in normal mucosa or adenoma (7% in both) ( P < .001). Positive staining in primary carcinomas correlated with younger age (n = 130) ( P = .008), presence of distant metastasis (n = 130) ( P = .043), and non–high-frequency microsatellite instability status (as detected by the standard polymerase chain reaction method using the 5 National Cancer Institute–recommended markers) (n = 77) ( P = .006). Positive staining in primary carcinomas also correlated with a worse 5-year disease-specific survival ( P = .04) on univariate but not multivariate analysis. Thus, our data show that there is selective expression of FR α in some colorectal cancers, providing a foundation for investigating the use of folate conjugates for imaging and therapy of colorectal tumors. Furthermore, our results suggest that a possible association exists between FR α expression and the microsatellite instability status in colorectal carcinoma. The significance of such an association as well as the prognostic value of FR α expression deserves further exploration.